Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort

[1]  C. Kalbaugh,et al.  Poor glycemic control is associated with significant increase in major limb amputation and adverse events in the 30-day postoperative period after infrainguinal bypass. , 2020, Journal of vascular surgery.

[2]  S. Pancholy,et al.  Peripheral arterial disease in women: The gender effect. , 2020, Cardiovascular revascularization medicine : including molecular interventions.

[3]  L. Kriston,et al.  Comorbidity Patterns Among Patients with Peripheral Arterial Occlusive Disease in Germany: A Trend Analysis of Health Insurance Claims Data. , 2019, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[4]  J. Lewinger,et al.  Preoperative hemoglobin A1c levels and increased risk of adverse limb events in diabetic patients undergoing infrainguinal lower extremity bypass surgery in the Vascular Quality Initiative. , 2019, Journal of vascular surgery.

[5]  W. Hiatt,et al.  Inflammatory Cytokines Associated With Failure of Lower-Extremity Endovascular Revascularization (LER): A Prospective Study of a Population With Diabetes , 2019, Diabetes Care.

[6]  Ximin Fan,et al.  Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study , 2019, Cardiovascular diabetology.

[7]  P. Deedwania,et al.  SGLT-2 Inhibitors and Peripheral Artery Disease: A Statistical Hoax or Reality? , 2019, Current problems in cardiology.

[8]  N. Bonadia,et al.  Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease , 2019, Cardiovascular Diabetology.

[9]  Y. Ko,et al.  Sex Differences in Outcomes Following Endovascular Treatment for Symptomatic Peripheral Artery Disease: An Analysis From the K‐VIS ELLA Registry , 2019, Journal of the American Heart Association.

[10]  N. Bonadia,et al.  Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects , 2019, Cardiovascular Diabetology.

[11]  K. Mahaffey,et al.  Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial. , 2018, Journal of the American College of Cardiology.

[12]  T. Craven,et al.  Effect of Intensive Glycemic Control on Risk of Lower Extremity Amputation. , 2018, Journal of the American College of Surgeons.

[13]  Sandeep R. Das,et al.  2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. , 2018, Journal of the American College of Cardiology.

[14]  J. Afilalo,et al.  Frailty assessment in older adults undergoing interventions for peripheral arterial disease. , 2018, Journal of vascular surgery.

[15]  Y. Ko,et al.  Baseline Characteristics of a Retrospective Patient Cohort in the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry , 2017, Korean circulation journal.

[16]  L. Fleisher,et al.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[17]  Freya J. I. Fowkes,et al.  Peripheral artery disease: epidemiology and global perspectives , 2017, Nature Reviews Cardiology.

[18]  Elizabeth W. Duggan,et al.  Poor glycemic control is a strong predictor of postoperative morbidity and mortality in patients undergoing vascular surgery , 2016, Journal of vascular surgery.

[19]  Deepak L. Bhatt,et al.  Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c. , 2016, The American journal of medicine.

[20]  Mohammad Hassan Murad,et al.  The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. , 2016, Journal of vascular surgery.

[21]  J. Mckinsey,et al.  Correction: Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication (Journal of Vascular Surgery (2015) 61(3S) (2S-41S)) , 2015 .

[22]  M Hassan Murad,et al.  Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. , 2015, Journal of vascular surgery.

[23]  E. Amsterdam,et al.  Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty , 2014, Vascular medicine.

[24]  I. Shimomura,et al.  The Influence of Glycemic Control on the Prognosis of Japanese Patients Undergoing Percutaneous Transluminal Angioplasty for Critical Limb Ischemia , 2010, Diabetes Care.

[25]  Grant D. Huang,et al.  Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.

[26]  Diederick Grobbee,et al.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.

[27]  Michael E. Miller,et al.  Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.

[28]  Neil R. Powe,et al.  Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.

[29]  L. Groop,et al.  Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. , 2003, Diabetes care.

[30]  T. Mueller,et al.  Impact of atherosclerotic risk factors on the anatomical distribution of peripheral arterial disease. , 2001, International angiology : a journal of the International Union of Angiology.

[31]  A. Boulton,et al.  Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. , 2001, Diabetes care.

[32]  R. Rutherford,et al.  Recommended standards for reports dealing with lower extremity ischemia: revised version. , 1997, Journal of vascular surgery.

[33]  P. Wilson,et al.  High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization , 2018, Journal of Vascular Surgery.

[34]  M. Özkaya,et al.  Action to Control Cardiovascular Risk in Diabetes , 2013 .

[35]  S. Schinner.  Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .

[36]  S. Schinner.  Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2009 .

[37]  S. Schinner.  Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes , 2009 .

[38]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[39]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..